authors request that the following error be noted on p. 1272, in the second paragraph from the bottom of the right-hand column. The bacteriophage T4 gene identified by Belfort and colleagues (ref. 53) as containing an intron encodes thymidylate synthase, not thymidine kinase.
Correction. In the article "Speculations on the early course of evolution" by J. E. Darnell and W. F. Doolittle, which appeared in number 5, March 1986, ofProc. Natl. Acad. Sci. USA (83, 1271-1275), the authors request that the following error be noted on p. 1272, in the second paragraph from the bottom of the right-hand column. The bacteriophage T4 gene identified by Belfort and colleagues (ref. 53) as containing an intron encodes thymidylate synthase, not thymidine kinase. 30 Glu-Glu-Lys-Ala-Gly-Arg-Lys-Glu-Arg-Lys-Lys-Glu-Val- 40 Val-Glu-Glu-Glu -Glu-Asn-Gly-Ala-Glu-Glu-Glu-Glu-Gluso 80
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Arg-Gln-Lys-Thr-Glu Asn-Gly-Ala-Ser-AlaOH. The blockmg group at the NH2 terminus was identified by mass spectrometry as acetyl. Regions homologous to amino acid sequences in prothymosin a were found to be located between residues 14-20, 23-25, 33-39, 41-43, and 83-87 of parathymosin.
Parathymosin was first isolated from rat thymus (1) as a by-product of the procedure used for the isolation of prothymosin a. It was named parathymosin because of its structural similarity to prothymosin a, the putative precursor of thymosin a1 (2, 3) . Parathymosin, like prothymosin a, was found to be devoid of aromatic and sulfur-containing amino acids. It (5, 6) , can protect mice against opportunistic infections and, indeed, may be'active at lower doses than thymosin a, (1) . Parathymosin did not exhibit this activity but it did appear to block the effects of prothymosin a. Its tissue distribution was also different from that of prothymosin a, with significantly higher concentrations found in liver and kidney than in thymus.-
In the present paper, we report a simplified procedure for the isolation of both peptides from rat thymus and the nearly complete amino acid sequence ofparathymosin. A procedure for the isolation of parathymosin from rat liver, a richer source for this peptide, is also described.
MATERIALS AND METHODS
Materials. Rat tissues were collected immediately after sacrifice of the animals by decapitation, frozen in liquid N2, and stored at -70'C. Other materials were from sources identified earlier (1, 3, 4) .
Methods. Chromatography on Sephacryl S-200 was carried out as described (1) . For the HPLC, a Waters Associates system with an Altex Ultrasphere ODS C18 column was used.
Protein and peptide analyses were carried out fluorometrically following alkaline hydrolysis and reaction with fluorescamine (7) . Automated sequence analysis was as described (3) . The quantitative radioimmunoassay for prothymosin a was as described by Haritos 9 .0 with K2CO3. After 4 hr at 50°C, the solution was acidified with 26 ul of concentrated HCOOH, diluted with 10 ml of buffer A (1 M HCOOH/0.2 M pyridine, pH 2.8) and pumped through a Sep-Pak C18 cartridge. After the cartridge was washed with 10 ml of buffer A, the peptides were eluted with 3 ml of 40% acetonitrile in buffer A, and the eluate was lyophilized.
Digestion with Staphylococcus aureus V8 protease was in 25 ,ul of 0.1 M NH4HCO3 containing 50 ,ug of peptide, 2 mM EDTA, and 1.67 ,ug of protease. After 13 hr at 37°C, the solution was lyophilized.
For the isolation of peptides in the proteinase digests and after treatment with H2NOH, the lyophilized solutions were dissolved in buffer A and separated by HPLC using the ODS C18 columns and a gradient of 0-40% acetonitrile in buffer A.
Hydrolysis of Asp-Pro bonds with HCOOH was by the procedure of Landon (9) the solution was lyophilized. Peptides formed with this procedure were separated by HPLC as described above with a gradient of 0-90% acetonitrile in 0.1% trifluoroacetic acid.
Isolation of Prothymosin a and Parathymosin from Rat Thymus. A modification of the published procedure (10, 11) has been developed that avoids the requirement for desalting on Sep-Pak cartridges and is more convenient for larger scale preparations. The recoveries of both prothymosin a and parathymosin are significantly improved. In this procedure, the pulverized frozen thymus tissue was added to boiling water (1 g per 14 ml) in place of the phosphate buffer used previously. The boiled tissue suspension was homogenized with a Polytron homogenizer as described (2) , and the extract obtained after centrifugation was treated at 40C with an equal volume of buffer A. The precipitate was removed by centrifugation at 16,000 x g for 30 min, and the clear supernatant solution was concentrated on a Speed Vac (Savant). The peptides were then separated by chromatography on Sephacryl S-200 followed by HPLC as described (1, 10, 11) .
For experiments on the biological activities of parathymosin, the product obtained after the first HPLC separation with a gradient of 1-propanol in buffer A (1) 
RESULTS
Comments on the Parathymosin Procedures. The modified procedures described here make available larger quantities of parathymosin and prothymosin a than the methods previously available. The recoveries from 10 g of rat thymus were approximately 700 ,g of prothymosin and 300 ,g of parathymosin. Processing of 10 g of rat liver yielded approximately 500 ,ug of parathymosin, but the quantity of prothymosin recovered from liver was too small to be ofinterest (see Fig. 1 ). Both products were homogeneous when evaluated by HPLC with the 1-propanol/buffer A system and by isoelectric focusing. However, parathymosin recovered from rat thymus was resolved into two peaks on HPLC using a gradient of acetonitrile (data not shown). This was not observed with parathymosin from liver, which was free of impurities in every test. The absence of isoleucine, aromatic amino acids, and sulfur-containing amino acids confirmed the purity of the rat liver parathymosin preparation.
Sequence Analysis. Automated sequence analysis of parathymosin, purified from either thymus or liver, confirmed the presence of a blocked NH2 terminus (2, 3) . Digestion with clostripain yielded six major peaks, one of which, designated C6, had the amino acid composition previously reported for residues 1-29 of parathymosin (1).
The structure of this peptide, including the presence of the NH2-terminal acetyl group, was confirmed by mass spectrographic analyses. The observed molecular mass was 3216.9, compared with a theoretical value of 3216.4 calculated from the amino acid sequence for residues 1-29 as shown in Fig. 2 . The theoretical value for the N-formyl derivative would be 3202.4. The observed molecular weight also confirms the assignment of glutamyl and aspartyl residues at the positions shown.
The remainder of the sequence was deduced from automated sequence analysis of the peptides formed by digestion with clostripain, S. aureus V8 protease, and hydrolysis with hydroxylamine or formic acid (Fig. 2) . The overlap from residues 29-35 had been established previously by analysis of thermolysin peptides (ref. 1 and unpublished data). Identical results were obtained with peptides derived from rat thymus parathymosin or from rat liver parathymosin for peptides C5, H2, C4, and C1. Digestion of rat liver parathymosin with thermolysin as described by Haritos et al. (1) yielded peptides with amino acid compositions corresponding to residues 5-10, 11-15, , and 16-35. The sequences of these peptides were confirmed by automated sequence analysis.
The results indicate that the same peptide is present in thymus and liver. A sequence of 24 residues with the presumed composition Asx7Glxl4Gly3, deduced from the estimated amino acid AcSer-Lys-Ser-Glu-Val-Glu-Ala-Ala-Ala-Glu-Leu-Ser-Ala-Lys-Asp- Leu-Lys-Glu-Lys-Lys-Asp-Lys-VaI-Glu-Glu-Lys-Ala-Gly-Arg-Lys-
Glu-Arg-Lys-Lys-Glu-Val-Val -G;lu-Glu-Glu -Glu-Asn-Gly-Ala- Glu-50   80 Glu-Glu-Glu-Glu-Glu-Thr-Ala-Glu -(GIy3,Asx 7,Glx1 4)-Glu-Gly-Pro-
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The amino acid sequence of parathymosin. Peptides formed by treatment with clostripain, S. aureus V8 protease, hydroxylamine, and formic acid are designated C, S, H, and F, respectively. The numbers refer to their order of elution in HPLC or, in the case of S. aureus protease, the elution positions of the peak fraction used for sequence analysis. The amino acid content of the missing segment (Gly3Asx4Glxl4, residues 54-77) was calculated from the composition of peptides C5, H2, and S1 and must be considered as approximate. and by 7 in another case, with the displacements occurring in opposite directions. The distribution of the two peptides, with prothymosin a predominating in thymus and spleen and parathymosin present in higher concentrations in nonlymphoid tissues, provides important clues to their biological function.
